Related Experiment Video
Updated: Mar 21, 2026

Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection
Published on: September 22, 2023
Importance and usage of the CHA2DS2-VASc score in predicting acute stent thrombosis
Sefa Ünal1, Burak Açar, Çağri Yayla
1Department of Cardiology, Turkey Yüksek İhtisas Education and Research Hospital, Ankara, Turkey.
Insights
The CHA2DS2-VASc score predicts stent thrombosis (ST) in patients without atrial fibrillation (AF) after percutaneous coronary intervention. A score above 2 independently indicates a higher risk of ST, offering a new predictive tool.
Area of Science:
- Cardiology
- Interventional Cardiology
- Thrombosis Research
Background:
- The CHA2DS2-VASc score is established for thromboembolic risk in atrial fibrillation (AF).
- Its predictive utility in patients undergoing percutaneous coronary intervention (PCI) without AF is not well-defined.
- Stent thrombosis (ST) remains a significant complication post-PCI.
Purpose of the Study:
- To evaluate the predictive value of the CHA2DS2-VASc score for ST in AF-free patients post-stent implantation.
- To determine if the CHA2DS2-VASc score can identify individuals at higher risk of acute ST.
Main Methods:
- Retrospective analysis of 1371 patients undergoing PCI.
- Calculation of CHA2DS2-VASc scores prior to PCI.
- Comparison of CHA2DS2-VASc scores between patients with (ST+) and without (ST-) acute stent thrombosis.
Main Results:
- The average CHA2DS2-VASc score was significantly higher in the ST+ group (3.79) compared to the ST- group (2.16).
- A positive correlation was observed between CHA2DS2-VASc scores and ST incidence.
- Multivariate analysis confirmed CHA2DS2-VASc score as an independent predictor of acute ST.
Conclusions:
- A CHA2DS2-VASc score greater than 2 is an independent predictor of ST in AF-free patients post-PCI.
- This study is the first to demonstrate the role of the CHA2DS2-VASc score in predicting ST in this specific population.
Objective:
The CHA2DS2-VASc score is used to estimate thromboembolic risk in atrial fibrillation (AF). Its usefulness in predicting outcome in patients after a percutaneous coronary intervention is unknown. We aimed to evaluate the predictive value of the CHA2DS2-VASc score in AF-free patients who have undergone stent implantation.
Design:
Patients were evaluated retrospectively. Among the 1371 patients, 38 presented with acute stent thrombosis (ST) and were included in the study. The CHA2DS2-VASc score was calculated before percutaneous coronary intervention and the association between the score and stent thrombosis was investigated.
Results:
The patients were grouped into ST (+) and ST (-). The average CHA2DS2-VASc score for the ST (+) group was 3.79, whereas that for the ST (-) group was 2.16 (P<0.001). A direct correlation was observed between CHA2DS2-VASc scores and the rate of ST. When patients with a CHA2DS2-VASc score of greater than 2 were compared with those with a CHA2DS2-VASc score of up to 2, the higher score had a higher frequency of ST (P<0.001) and multivariate analysis identified the CHA2DS2-VASc score as an independent predictor of acute ST.
Conclusion:
A CHA2DS2-VASc score of greater than 2 was found to be an independent predictor for incidence of ST. The role of the CHA2DS2-VASc score in predicting ST has not been investigated earlier in an AF-free population and our study is the first to explore this aspect.
More Related Videos
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome V: Nursing Management

